User profiles for Timothy Bergquist
 | Timothy BergquistData Scientist, Mt Sinai Institute for Genomic Health Verified email at mssm.edu Cited by 1770 |
Federated benchmarking of medical artificial intelligence with MedPerf
Medical artificial intelligence (AI) has tremendous potential to advance healthcare by
supporting and contributing to the evidence-based practice of medicine, personalizing patient …
supporting and contributing to the evidence-based practice of medicine, personalizing patient …
The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens
N Zhou, Y Jiang, TR Bergquist, AJ Lee, BZ Kacsoh… - Genome biology, 2019 - Springer
Background The Critical Assessment of Functional Annotation (CAFA) is an ongoing, global,
community-driven effort to evaluate and improve the computational annotation of protein …
community-driven effort to evaluate and improve the computational annotation of protein …
The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification
The BraTS 2021 challenge celebrates its 10th anniversary and is jointly organized by the
Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR…
Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR…
Characterizing long COVID: deep phenotype of a complex condition
Background Numerous publications describe the clinical manifestations of post-acute
sequelae of SARS-CoV-2 (PASC or "long COVID"), but they are difficult to integrate because of …
sequelae of SARS-CoV-2 (PASC or "long COVID"), but they are difficult to integrate because of …
Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance
…, JMO Rañola, C Smith, LT Garrett, T Bergquist… - Genetics in …, 2019 - nature.com
Purpose Family studies are an important but underreported source of information for
reclassification of variants of uncertain significance (VUS). We evaluated outcomes of a patient-…
reclassification of variants of uncertain significance (VUS). We evaluated outcomes of a patient-…
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
Background Stratification of patients with post-acute sequelae of SARS-CoV-2 infection (PASC,
or long COVID) would allow precision clinical management strategies. However, long …
or long COVID) would allow precision clinical management strategies. However, long …
[HTML][HTML] Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C)
…, N Kuhrt, YR Shao, F Liu, T Bergquist… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-19
has been reported from relatively small cohorts. The NCATS’National COVID Cohort …
has been reported from relatively small cohorts. The NCATS’National COVID Cohort …
[HTML][HTML] Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the National COVID Cohort Collaborative
…, F Liu, V Madhira, AK Mitra, T Bergquist… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-19
infections in vaccinated patients with cancer using the largest national cohort of COVID-19 …
infections in vaccinated patients with cancer using the largest national cohort of COVID-19 …
The brain tumor segmentation (BRATS) challenge 2023: Focus on pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
Pediatric tumors of the central nervous system are the most common cause of cancer-related
death in children. The five-year survival rate for high-grade gliomas in children is less than …
death in children. The five-year survival rate for high-grade gliomas in children is less than …
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the US National …
Objective To assess whether rituximab (RTX) is associated with worse COVID-19 outcomes
among patients with rheumatoid arthritis (RA). Methods We used the National COVID Cohort …
among patients with rheumatoid arthritis (RA). Methods We used the National COVID Cohort …